CHMP Gives a Positive Opinion for the Use of VELCADE A as Retreatment and for Frontline Induction Therapy before Stem Cell Transplantation )--Janssen-Cilag International NV announced today that The Committee for Medical Products for Human Use of The European Medicines Agency has granted a positive opinion on two variations relating to the use of ... (more)
http://www.businesswire.com/news/home/20130628005393/en/CHMP-Positive-Opinion-VELCADE%C2%AE-Retreatment-Frontline-Induction
http://www.businesswire.com/news/home/20130628005393/en/CHMP-Positive-Opinion-VELCADE%C2%AE-Retreatment-Frontline-Induction
No comments:
Post a Comment